1
/
of
0
FDA Adverse Event Narratives – Semaglutide (Pre-July 22, 2024)
FDA Adverse Event Narratives – Semaglutide (Pre-July 22, 2024)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: I would like to request electronic copies, sent to me email, of the summary narratives of the following adverse events related to semaglutide, all of which were received by the FDA before July 22, 2024: (Case ID) 24369000, 24364699, 24335828, 24296166, 24251668, 24221346, 24198657, 24173304, 24165100, 24134594, 24116249, 24116248
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details